Development of a comprehensive in silico platform for the prediction and analysis of protein - noble gas interactions and potential therapeutic applications across the entire human proteome.
The placentus is a new paradigm for management of monochorionic pregnancies: the creation of software system for non-invasive previsualization of superficial vasculature of placentas for improved prognosis and for improved prognosis and planning of fetoscopic laser therapy.
The present project aims to the development of a platform for medical decision making from the integration of clinical data, massive sequencing of exomas and metabolic of the analysis of liquid biopsies of patients with breast cancer with a computational system to improve the precision medicine
The scope of this project is to complete the r&d required for obtaining the market authorization of a new recombinant vaccine against canine leishmaniasis, which has been shown protective in experimental trials in dogs with better performance than that of gold-standards.
This project aims at developing a novel, wireless recording system that is able to perform continuous recording of field potentials from the surface of the brain for research and diagnostic purposes.
The aim of this project is to develop applying new technologies, a natural feed supplements based on beer yeast, as a inactive powder for new feed receipts
To create the first cost-effective product that integrates a coherent supercontinuum laser with a programmable ultrashort pulse management system for microscopy and imaging purposes, allowing to overcome current imaging barriers to massively deploy multiphoton excitation (mpe) technology.
Biomedal has codeveloped a method for the detection of gluten peptides in urine samples to know when gluten has been ingested. This project aims to develop the first home test with sufficient sensitivity and simplicity to control the adherance to the gluten free diet in celiac patients
The mission of the consortium is to implement a rational drug discovery approach to develop innovative platform of technologies, therapeutic and prophylactic strategies for the prevention and/or treatment of alzheimer's disease and related neurodegenerative disorders.
The project will address the urgent need for new drugs to effectively combat infections caused by flaviviruses such as zika or dengue virus through blocking a protein critical to their lifecycle using innovative macrocyclic chemistry.